| Company/Division name | Kite Pharma |
| Parent company | Gilead Sciences, Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 500 |
| Year reshoring announced: | 2019 |
| Year reshoring implemented or to be implemented: | 2026 |
| City reshored to: | Frederick County |
| State(s) reshored to: | MD |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharma |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Government Incentives, Infrastructure, Proximity to customers/market |
| Government Incentive dollar amount: | 1.5 |
